Neurology - Patients With MG

What do you know about plasma exchange?

Relatively safe
Outpatient setting
Peripheral venous access
Lasts about 2 hours

Article Summary: Safety of Plasma Exchange Therapy in Patients with Myasthenia Gravis
Authors: Ebadi H, Barth D, Bril V

This article summary assesses the safety of plasma exchange in patients with moderate to severe myasthenia gravis (MG) and provides treatment guidance.

Fields marked * are required.

First Name *

Last Name *

Email Address *

Title *

Company Name/Hospital *

Country *

How many MG patients do you treat per year?

Do you prescribe plasma exchange for your neuromuscular patients?

What are your treatment challenges with neuromuscular patients? (Select all that apply): Treatment costs Patient safety Convenience of therapy Time until patient’s response to treatment (time it takes to get an accurate diagnosis for a patient) Time of patient’s recovery (determining which treatment option will most quickly stabilize the patient so recovery can begin)

Questions/Comments:

* I confirm that I have read and agree to the Terumo BCT Privacy Policy.

Yes, I would like to receive future communications about Terumo BCT.

Prospect Source

Prospect Source (Most Recent Touch)

Prospect Source (First Touch)

Last SFDC Campaign ID

Lead Source Original

Product Family

Business

Status